CRISPR Therapeutics AG reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Zug
SEC filing record 1 source field available
Fiscal year end
31 December
CRISPR Therapeutics AG has filed 853 SEC EDGAR filings since 13 May 2016

SEC filing history

Showing 551-575 of 853 matching filings.

Per page
25
Current page
23
4

FORM 4 SUBMISSION

Filing date
01 May 2019
Reporting date
29 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37923

DEFA14A

Filing date
30 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37923

DEF 14A

Filing date
30 Apr 2019
Reporting date
11 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
30 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
29 Apr 2019
Reporting date
29 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-37923

PRER14A

Filing date
29 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-37923

PRER14A

Filing date
23 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37923

PRE 14A

Filing date
09 Apr 2019
Reporting date
11 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2019
Reporting date
05 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2019
Reporting date
05 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2019
Reporting date
05 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2019
Reporting date
05 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2019
Reporting date
05 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Mar 2019
Reporting date
01 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Mar 2019
Reporting date
01 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Feb 2019
Reporting date
25 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
25 Feb 2019
Reporting date
25 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37923

8-K

Filing date
25 Feb 2019
Reporting date
25 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89674

NEW ENTERPRISE ASSOCIATES 15, L.P. / CRISPR THERAPEUTICS AG - 13G/A (#2)

Filing date
12 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .